selected publications
- Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression Profiles. 2024 GET IT
- Fibrin associated large B-cell lymphoma accidentally identified in a breast implant capsule: a molecular report of a rare entity. 2024 GET IT
- Follicular melanoma-A rare entity: First description of an association with a nevus. Experimental dermatology. 2024 Letter GET IT
- Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused by PARP inhibition. Science signaling. 2024 Academic Article GET IT
- Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring. Cancers. 2024 Editorial Article GET IT
- Distinct mesenchymal cell states mediate prostate cancer progression. Nature communications. 2024 Academic Article GET IT
- Shedding light on PRAME expression in dysplastic nevi: a cohort study. Virchows Archiv : an international journal of pathology. 2023 Academic Article GET IT
- Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancer. Pathologica. 2023 Review GET IT
- Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. Journal of translational medicine. 2023 Academic Article GET IT
- Genetic relationship between the immune system and autism. Brain, behavior, & immunity - health. 2023 Academic Article GET IT
-
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey.
Critical reviews in oncology/hematology.
2023
Review
GET IT
Times cited: 3 -
Value of Artificial Intelligence in Evaluating Lymph Node Metastases.
Cancers.
2023
Review
GET IT
Times cited: 25 - Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol. Critical reviews in oncology/hematology. 2023 Review GET IT
-
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.
Genes.
2023
Academic Article
GET IT
Times cited: 6 -
Epidemiology of Merkel cell carcinoma in Tuscany (Italy), 2006-2021.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP).
2023
Academic Article
GET IT
Times cited: 1 -
Cervical Adenocarcinoma: A Still Under-investigated Malignancy.
Anticancer research.
2023
Academic Article
GET IT
Times cited: 1 - Pre-Implantation Kidney Biopsies in Extended Criteria Donors: From On Call to Expert Pathologist, from Conventional Microscope to Digital Pathology. Critical reviews in oncogenesis. 2023 Academic Article GET IT
- The prostate stromal transcriptome in aggressive and lethal prostate cancer. Molecular cancer research : MCR. 2022 Academic Article GET IT
- Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine. Cancers. 2022 Review GET IT
-
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.
Genes.
2022
Academic Article
GET IT
Times cited: 17 - Pyruvate kinase M1 suppresses development and progression of prostate adenocarcinoma. Cancer research. 2022 Academic Article GET IT
-
Is It Time to Consider the Androgen Receptor as a Therapeutic Target in Breast Cancer?.
Anti-cancer agents in medicinal chemistry.
2022
Review
GET IT
Times cited: 6 -
Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients.
Journal of clinical medicine.
2021
Academic Article
GET IT
Times cited: 11 -
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.
Histology and histopathology.
2021
Review
GET IT
Times cited: 22 -
Epstein-Barr virus associated gastric dysplasia: a new rare entity?
2021
GET IT
Times cited: 2 - Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy. 2021 GET IT
-
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Clinical neurology and neurosurgery.
2021
Academic Article
GET IT
Times cited: 60 -
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.
Genes.
2021
Review
GET IT
Times cited: 72 -
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy.
Investigational new drugs.
2021
Academic Article
GET IT
Times cited: 4 -
New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes.
Scientific reports.
2021
Academic Article
GET IT
Times cited: 13 -
Stem cells for treatment of cardiovascular diseases: An umbrella review of randomized controlled trials.
Ageing research reviews.
2021
Review
GET IT
Times cited: 8 -
Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.
Molecular cancer research : MCR.
2020
Academic Article
GET IT
Times cited: 24 -
Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization.
Frontiers in oncology.
2020
Review
GET IT
Times cited: 33 -
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.
Cancer cell international.
2020
Review
GET IT
Times cited: 67 -
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases.
2019
GET IT
Times cited: 2 -
Calcific Myonecrosis of the Leg: A Rare Entity.
Medicina (Kaunas, Lithuania).
2019
Review
GET IT
Times cited: 4 -
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis.
International journal of surgical pathology.
2019
Academic Article
GET IT
Times cited: 9 -
Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status.
Pathology, research and practice.
2019
Letter
GET IT
Times cited: 7 -
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.
British journal of cancer.
2019
Academic Article
GET IT
Times cited: 67 - Rosai-Dorfman Disease: Case Report of an Unusual Testicular Involvement and Review of Literature. Clinical genitourinary cancer. 2019 Review GET IT
-
Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 63 -
LONG-NONCODING RNAs in gastroesophageal cancers.
Non-coding RNA research.
2018
Information Resource
GET IT
Times cited: 34 -
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases.
Cancer cell international.
2018
Academic Article
GET IT
Times cited: 7 -
Cerebral Lymphoproliferation in a Patient with Kabuki Syndrome.
Journal of clinical immunology.
2018
Letter
GET IT
Times cited: 5 -
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa.
World journal of gastroenterology.
2017
Editorial Article
GET IT
Times cited: 9 -
PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions.
Histopathology.
2017
Academic Article
GET IT
Times cited: 26 -
A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma.
The American journal of pathology.
2011
Academic Article
GET IT
Times cited: 42